Biomerieux SA
PAR:BIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomerieux SA
PAR:BIM
|
FR |
|
B
|
BioXcel Therapeutics Inc
F:BX2
|
US |
|
O
|
Onesource Specialty Pharma Ltd
NSE:ONESOURCE
|
IN |
|
C
|
CI Banco SA Institucion de Banca Multiple FF/00939
BMV:TERRA13
|
MX |
|
Red Electrica Corporacion SA
MAD:RED
|
ES |
|
Legrand SA
F:LRC
|
FR |
|
J
|
Jones Lang LaSalle Inc
SWB:4J2
|
US |
|
D
|
DICK'S Sporting Goods Inc
F:DSG
|
US |
|
O
|
ONEOK Inc
F:ONK
|
US |
|
H
|
H & R Block Inc
F:HRB
|
US |
|
FedEx Corp
NYSE:FDX
|
US |
|
Rush Enterprises Inc
NASDAQ:RUSHA
|
US |
|
Thesis Gold Inc
F:0110
|
CA |
|
M
|
Mitsui & Co Ltd
XMUN:MTS1
|
JP |
|
H
|
Heidelberg Materials AG
F:HEIU
|
DE |
|
CapitaLand Integrated Commercial Trust
OTC:CPAMF
|
SG |
|
STRABAG SE
F:XD4
|
AT |
|
O
|
Olin Corp
F:OLN
|
US |
|
Ranpak Holdings Corp
F:0ZA
|
US |
|
Airtel Africa PLC
OTC:AARTY
|
UK |
|
H
|
Hyundai BNG Steel Co Ltd
KRX:004565
|
KR |
|
E
|
eBay Inc
XMUN:EBA
|
US |
|
Guotai Junan Securities Co Ltd
OTC:GUOSF
|
CN |
|
D
|
DCON Products PCL
SET:DCON
|
TH |
Wall St Price Targets
BIM Price Targets Summary
Biomerieux SA
According to Wall Street analysts, the average 1-year price target for BIM is 81.79 EUR with a low forecast of 64.64 EUR and a high forecast of 105 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIM's stock price target?
Price Target
81.79
EUR
According to Wall Street analysts, the average 1-year price target for BIM is 81.79 EUR with a low forecast of 64.64 EUR and a high forecast of 105 EUR.
What is the Revenue forecast for Biomerieux SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Biomerieux SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Biomerieux SA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 8%.
What is the Pre-Tax Income forecast for Biomerieux SA?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Biomerieux SA?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 14%.
